US Patent

US7862832 — Generally linear effervescent oral fentanyl dosage form and methods of administering

Formulation · Assigned to Cima Labs Inc · Expires 2028-06-15 · 2y remaining

Vulnerability score 60/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a generally linear effervescent oral fentanyl dosage form and methods for administering it.

USPTO Abstract

Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.

Drugs covered by this patent

Patent Metadata

Patent number
US7862832
Jurisdiction
US
Classification
Formulation
Expires
2028-06-15
Drug substance claim
No
Drug product claim
Yes
Assignee
Cima Labs Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.